Programme overview 2024

End of the meeting & Lunch

Time: 13:00 - 14:00 CET

Round table discussion

Time: 12:40 - 13:00 CET

Breast Cancer

Time: 12:25 - 12:40 CET

Amad Awada, Bordet Institute

Prevention, risk reduction, and genetics

Time: 12:10 - 12:25 CET

Sofie Joris, UZ Brussel

Round table discussion

Time: 11:50 - 12:10 CET

Gynecologic cancer

Time: 11:35 - 11:50 CET

Jean-Francois Baurain, UCL St Luc

Genitourinary cancer

Time: 11:20 - 11:35 CET

Annelies Verbiest, UZA

Break

Time: 10:50 - 11:20 CET

Meeting report from the young inv contributions

Time: 10:40 - 10:50 CET

Round table discussion

Time: 10:20 - 10:40 CET

Thoracic oncology

Time: 10:05 - 10:20 CET

Guy Berchem, CHL de Luxembourg

Digestive oncology

Time: 09:50 - 10:05 CET

Karen Geboes, UZ Gent

Round table discussion

Time: 09:30 - 09:50 CET

H&N, sarcoma, symptom science and palliative care

Time: 09:15 - 09:30 CET

Sylvie Rottey, UZ Gent

Registrations

Time: 08:30 - 09:00 CET

Melanoma & non-melanoma skin cancers, CNS tumors

Time: 09:00 - 09:15 CET

Bart Neyns, UZ Brussel

Break

Time: 11:00 - 11:25 CET

Breast cancer

Time: 12:45 - 13:05 CET

Lunch

Time: 13:10 - 14:10 CET

Gynecological cancer

Time: 11:55 - 12:15 CET

Genitourinary cancer

Time: 11:30 - 11:50 CET

ASCO Highlights

Time: 10:15 - 10:35 CET

50 Lung cancer

Time: 09:50 - 10:10 CET

Gastrointestinal cancer

Time: 09:25 - 09:45 CET

Melanoma / skin cancers

Time: 09:00 - 09:20 CET

Registration

Time: 08:30 - 09:00 CET

Concluding remarks

Time: 21:45 - 22:00 CET

Key considerations when treating with ADC : a practical discussion

Time: 21:05 - 21:40 CET

What about older patients with HER2-positive metastatic breast cancer?

Time: 20:45 - 21:00 CET

Break

Time: 20:30 - 20:45 CET

Completing the picture: Multidisciplinary insights for the treatment of patients with eBC

Time: 19:50 - 20:25 CET

Making sense of new treatment options in early breast cancer

Time: 19:30 - 19:45 CET

Registration and light buffet dinner

Time: 18:30 - 19:15 CET